Desmopressin
Desmopressin is a synthetic hormone used to reduce excess urination caused by central diabetes insipidus and to manage bedwetting in children.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 14 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Desmopressin: Patient Information Guide
A plain-language walkthrough of Desmopressin — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Desmopressin is approved to treat:
- Central diabetes insipidus — including cases triggered by head trauma or pituitary surgery
- Primary nocturnal enuresis (bedwetting) — used alone or with behavioral strategies
⚙️How it works▾
Desmopressin is a synthetic (lab-made) copy of the body's natural antidiuretic hormone (ADH), also called arginine vasopressin. It latches onto V2 receptors in the kidneys, telling them to pull more water back into the body rather than sending it out as urine. This reduces urine volume, concentrates the urine, and restores better fluid balance.
Compared to natural ADH, desmopressin has been structurally modified to last longer in the body and to act more selectively on the kidneys — with much less effect on blood vessels. That means it can control urine output without causing significant changes in blood pressure at typical doses.
💊How it's taken▾
Desmopressin tablets are taken by mouth, usually two to three times daily. The dose is always individualized — your prescriber will start low and adjust based on how your body responds.
- Food effect: A high-fat meal can sharply reduce absorption, so take it consistently with or without food as directed
- Fluid restriction: Limiting fluid intake is required — your prescriber will advise on how much
- Switching from nasal spray: If you were on intranasal desmopressin, your doctor will guide the transition timing
Never adjust your dose on your own. Regular check-ins with your prescriber help make sure the dose stays right for you.
🤒Side effects — in detail▾
The most commonly reported side effects include:
- Headache
- Nausea or vomiting
- Dizziness
- Abdominal cramps
- Swelling (edema)
- Fatigue
- High blood pressure
- Flushing or sweating
Serious reactions to watch for include signs of low sodium (confusion, unusual weight gain, nausea, headache, or seizures), difficulty urinating, or signs of a severe allergic reaction (trouble breathing, facial swelling). These need prompt medical attention.
⚠️Warnings & precautions▾
- Hyponatremia (low sodium): The most serious risk. Drinking too much fluid while on desmopressin can dilute sodium levels to dangerous or even fatal levels. Watch for headache, nausea, confusion, unusual weight gain, or seizures — and seek care immediately if these occur.
- Fluid retention: Can worsen heart failure or high blood pressure. Patients with these conditions need close monitoring.
- Illness interruptions: Stop desmopressin temporarily during vomiting, diarrhea, fever, or extreme heat/exercise — these situations can rapidly disrupt fluid and sodium balance.
- Psychogenic polydipsia: People who habitually drink large amounts of water are at especially high risk of water intoxication on this drug.
- Allergic reactions: Anaphylaxis has been reported with other desmopressin formulations.
🔀What it interacts with▾
Several medications can increase the risk of dangerously low sodium when combined with desmopressin — your sodium levels should be monitored more often if you take any of these:
- Antidepressants (SSRIs or tricyclics) — raise hyponatremia risk
- Thiazide diuretics (certain blood pressure/water pills) — increase risk of water retention and low sodium
- NSAIDs (like ibuprofen, naproxen) — can worsen sodium imbalance
- Carbamazepine or lamotrigine (seizure medications) — increase hyponatremia risk
- Chlorpromazine (antipsychotic) — raises water intoxication risk
- Opioid pain medications — can worsen low sodium
- Chlorpropamide (a diabetes drug) — increases hyponatremia risk
- Other vasoconstrictors (blood-vessel-narrowing drugs) — may raise blood pressure when combined with desmopressin
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- History of low sodium (hyponatremia): Do not take desmopressin — it is contraindicated
- Moderate to severe kidney disease (creatinine clearance below 50 mL/min): Do not take — the drug builds up and the risk of serious side effects is too high
- Heart failure or uncontrolled high blood pressure: Use with caution; fluid retention can worsen these conditions
- History of urinary retention: Not recommended
- Children: Fluid restriction is especially important; they are at higher risk of hyponatremia
- Older adults: Kidney function declines with age, increasing drug exposure — dose selection should be careful and kidney function monitored
- Cystic fibrosis, kidney disorders, or other fluid/electrolyte conditions: Need more frequent sodium monitoring
- Pregnancy: Available data have not shown increased birth defect risk, but discuss with your doctor — untreated central diabetes insipidus in pregnancy carries its own risks
🚑If you take too much▾
Taking too much desmopressin can cause confusion, drowsiness, persistent headache, difficulty urinating, and rapid weight gain from fluid buildup. There is no specific antidote. If an overdose is suspected, the dose should be reduced or stopped, and the person watched closely and treated for symptoms. Contact a poison control center or emergency services right away.
📡Pharmacodynamics — effects in the body▾
Desmopressin's main measurable effect in central diabetes insipidus is a significant reduction in urine output, an increase in urine concentration (osmolality), and a decrease in the concentration of the blood (plasma osmolality). The antidiuretic effect begins within about one hour of taking a tablet and reaches its peak effect at roughly four to seven hours. These effects allow most patients to sleep through the night and return to a more normal daily routine with fewer bathroom trips.
🔬Pharmacokinetics — how your body processes it▾
When taken orally, desmopressin is absorbed slowly and has very low bioavailability — only about 0.16% of the dose reaches the bloodstream, compared to an intravenous dose. A high-fat meal can reduce peak blood levels by about 72% and overall exposure by 64%, so meal timing matters. The drug's elimination half-life (how long it takes the body to clear half the dose) is about 3.6 hours under normal conditions, but this stretches significantly in people with kidney impairment — reaching up to 8.7 hours in severe cases. Desmopressin is eliminated mainly through the kidneys, which is why reduced kidney function raises drug exposure and risk.
📦How to store it▾
Store at Controlled Room Temperature 20 to 25°C (68 to 77°F) . Keep out of the reach of children.
📄 Written from Desmopressin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Desmopressin
17 supplements and herbal products have documented interactions with Desmopressin in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 7
- Minor · 9
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Desmopressin — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is this medication doing for me — why do I need it? ▾
Should I take it with food or on an empty stomach? ▾
What are the warning signs I should call about right away? ▾
Do I need to limit how much I drink while on this medication? ▾
Are there other medications I should watch out for? ▾
What should I do if I get sick with vomiting or diarrhea while taking this? ▾
Is Desmopressin available over the counter? ▾
When was Desmopressin first available? ▾
Who makes Desmopressin? ▾
💬 Answers drafted from Desmopressin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Desmopressin comes
Desmopressin is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
Injection
Nasal spray
Sublingual tablet
Oral solution
📊 Desmopressin across the U.S. market
How Desmopressin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (32) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Desmopressin is used
A general measure of how commonly Desmopressin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Desmopressin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Desmopressin prescribed? Of the 1,596 medications we measure, Desmopressin ranks #299 by Medicaid prescriptions — more than 81% of them.
Utilization by Desmopressin product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
desmopressin acetate 0.2 MG Oral Tablet Most dispensed
Summed across the 7 of 33 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 833008
desmopressin acetate 0.1 MG Oral Tablet
Summed across the 5 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 849515
desmopressin acetate 0.01 MG/ACTUAT Nasal Spray
Summed across the 3 of 9 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 849506
desmopressin acetate 0.004 MG/ML Injectable Solution
Summed across the 5 of 21 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 849501
1 ML desmopressin acetate 0.004 MG/ML Injection
Summed across the 6 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1723232
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Desmopressin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 26 of 115 listed Desmopressin NDCs with Medicaid activity.
🔍 Compare Desmopressin products
A representative set of FDA-listed product records for Desmopressin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 4 mcg/mL | Intravenous; Subcutaneous | American Regent, Inc. | ANDA | View NDC → |
| 4 mcg/mL | Intravenous | Amring Pharmaceuticals Inc. × 5 listings | NDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | Armas Pharmaceuticals Inc. | ANDA | View NDC → |
| 40 mcg/10 mL | Intravenous, Subcutaneous | Armas Pharmaceuticals Inc. | ANDA | View NDC → |
| 4 mcg/mL | Intravenous; Subcutaneous | Athenex Pharmaceutical Division, LLC. × 2 listings | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | Avenacy, Inc. | ANDA | View NDC → |
| 4 mcg/mL | Intravenous | Caplin Steriles Limited × 2 listings | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | Dr. Reddy's Laboratories Inc. | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | Dr.Reddys' Laboratories Inc | ANDA | View NDC → |
| 4 mcg/mL | Intravenous | Ferring Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | Fresenius Kabi USA, LLC × 2 listings | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | Gland Pharma Limited × 2 listings | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | Meitheal Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 4 mcg/mL | Intravenous | Nordic Pharma, Inc. × 5 listings | NDA | View NDC → |
| 4 mcg/mL | Intravenous; Subcutaneous | NorthStar RxLLC | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 4 mcg/mL | Intravenous; Subcutaneous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 40 mcg/10 mL | Intravenous, Subcutaneous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 40 mcg/10 mL | Intravenous; Subcutaneous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | Sun Pharmaceutical Industries, Inc. × 2 listings | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | Sun Pharmaceutical Industries Limited × 2 listings | ANDA | View NDC → |
| 4 mcg/mL | Intravenous | Teva Parenteral Medicines, Inc. × 2 listings | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | The J. Molner Company LLC × 2 listings | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | UBI Pharma Inc. × 2 listings | ANDA | View NDC → |
| 4 mcg/mL | Intravenous; Subcutaneous | UBI Pharma Inc. × 3 listings | ANDA | View NDC → |
| 40 mcg/10 mL | Intravenous, Subcutaneous | UBI Pharma Inc. | ANDA | View NDC → |
| 40 mcg/10 mL | Intravenous; Subcutaneous | UBI Pharma Inc. | ANDA | View NDC → |
| 4 mcg/mL | Intravenous, Subcutaneous | XGen Pharmaceuticals DJB, Inc. × 2 listings | ANDA | View NDC → |
| 💊Nasal spray | ||||
| 10 mcg | Nasal | Apotex Corp. × 3 listings | ANDA | View NDC → |
| 0.1 mg/mL | Nasal | Bauch & Lomb Incorporated × 3 listings | ANDA | View NDC → |
| 10 mcg | Nasal | Bryant Ranch Prepack | ANDA | View NDC → |
| 1.5 mg/mL | Nasal | Ferring Pharmaceuticals Inc. | NDA | View NDC → |
| 0.1 mg/mL | Nasal | Oceanside Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 0.1 mg/mL | Nasal | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 0.1 mg/mL | Nasal | Zydus Lifesciences Limited | ANDA | View NDC → |
| 0.1 mg/mL | Nasal | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 💊Oral solution | ||||
| 0.05 mg/mL | Oral | Eton Pharmaceuticals, Inc. | NDA | View NDC → |
| 💊Sublingual tablet | ||||
| 27.7 mcg | Sublingual | Antares Pharma, Inc. × 2 listings | NDA | View NDC → |
| 55.3 mcg | Sublingual | Antares Pharma, Inc. × 2 listings | NDA | View NDC → |
| 27.7 mcg | Sublingual | Ferring Pharmaceuticals Inc. | NDA | Find on DailyMed ↗ |
| 55.3 mcg | Sublingual | Ferring Pharmaceuticals Inc. | NDA | View NDC → |
| 💊Tablet | ||||
| 0.1 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 0.2 mg | Oral | Actavis Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 0.1 mg | Oral | American Health Packaging × 3 listings | ANDA | View NDC → |
| 0.2 mg | Oral | American Health Packaging × 4 listings | ANDA | View NDC → |
| 0.1 mg | Oral | Amring Pharmaceuticals Inc. | NDA | View NDC → |
| 0.2 mg | Oral | Amring Pharmaceuticals Inc. | NDA | View NDC → |
| 0.1 mg | Oral | Apotex Corp. × 3 listings | ANDA | View NDC → |
| 0.2 mg | Oral | Apotex Corp. × 3 listings | ANDA | View NDC → |
| 0.1 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 0.2 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 0.1 mg | Oral | BluePoint Laboratories × 3 listings | ANDA | View NDC → |
| 0.2 mg | Oral | BluePoint Laboratories × 3 listings | ANDA | View NDC → |
| 0.2 mg | Oral | Bryant Ranch Prepack | NDA | View NDC → |
| 0.2 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 0.1 mg | Oral | Ferring Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 0.2 mg | Oral | Ferring Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 0.1 mg | Oral | Glenmark Pharmaceuticals Inc.,USA × 2 listings | ANDA | View NDC → |
| 0.2 mg | Oral | Glenmark Pharmaceuticals Inc.,USA × 2 listings | ANDA | View NDC → |
| 0.1 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.2 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.1 mg | Oral | Kvk-tech, Inc. × 2 listings | ANDA | View NDC → |
| 0.2 mg | Oral | Kvk-tech, Inc. × 2 listings | ANDA | View NDC → |
| 0.1 mg | Oral | Nordic Pharma, Inc. | NDA | View NDC → |
| 0.2 mg | Oral | Nordic Pharma, Inc. | NDA | View NDC → |
| 0.1 mg | Oral | Northstar Rx LLC | ANDA | View NDC → |
| 0.2 mg | Oral | Northstar Rx LLC | ANDA | View NDC → |
| 0.2 mg | Oral | Northwind Health Company, LLC | ANDA | View NDC → |
| 0.2 mg | Oral | Northwind Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.1 mg | Oral | Remedyrepack Inc. × 3 listings | ANDA | View NDC → |
| 0.2 mg | Oral | Remedyrepack Inc. × 6 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 g/g | — | Aspen Oss B.V. | BULK INGREDIENT | View NDC → |
| 100 kg/100 kg | — | Assia Chemical Industries Ltd - Teva Tech Site | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Aurobindo Pharma Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Bachem Americas, Inc. | EXPORT ONLY | View NDC → |
| 1 g/g | — | Bcn Peptides Sa | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Hybio Pharmaceutical Co., Ltd. × 2 listings | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Nanjing Chengong Pharmaceutical Co., Ltd. × 2 listings | BULK INGREDIENT | View NDC → |
| 10 g/10 g | — | Pharma Source Direct, Inc. | BULK INGREDIENT | View NDC → |
| 5 g/5 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 7 g/7 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 10 g/10 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 20 g/20 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 25 g/25 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 53 g/53 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 57 g/57 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 60 g/60 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 80 g/80 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 85 g/85 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 115 g/115 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 120 g/120 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 123 g/123 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 150 g/150 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 200 g/200 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 250 g/250 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 257 g/257 g | — | Piramal Pharma Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | PolyPeptide Laboratories (Sweden) AB | BULK INGREDIENT | View NDC → |
| 4 g/4 g | — | PolyPeptide Laboratories (Sweden) AB | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Professional Compounding Centers of America | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Qingdao Biopeptek Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 g/g | — | ScinoPharm Taiwan Ltd. | BULK INGREDIENT | View NDC → |
Showing 160 of 160 products — FDA National Drug Code Directory. See every product, package size and price: browse all 160 Desmopressin NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Desmopressin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Desmopressin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Desmopressin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 3251 8 dose forms · 12 strengths
-
Dose form (SCDF) Injectable Solution RxCUI 371714In current FDA listingsClinical drug / strength (SCD) acetate 0.004 MG/MLRxCUI 849501 -
Dose form (SCDF) Injection RxCUI 1723231In current FDA listingsClinical drug / strength (SCD) 1 ML desmopressin acetate 0.004 MG/MLRxCUI 1723232 -
Dose form (SCDF) Metered Dose Nasal Spray RxCUI 1797858In current FDA listingsClinical drug / strength (SCD) acetate 0.00083 MG/ACTUATRxCUI 1874124acetate 0.00166 MG/ACTUATRxCUI 1874132acetate 0.15 MG/ACTUATRxCUI 1797859 -
Dose form (SCDF) Nasal Solution RxCUI 371715In current FDA listingsClinical drug / strength (SCD) acetate 0.1 MG/MLRxCUI 849520 -
Dose form (SCDF) Nasal Spray RxCUI 374371In current FDA listingsClinical drug / strength (SCD) acetate 0.01 MG/ACTUATRxCUI 849506 -
Dose form (SCDF) Oral Solution RxCUI 2738080In current FDA listingsClinical drug / strength (SCD) acetate 0.05 MG/MLRxCUI 2738083 -
Dose form (SCDF) Oral Tablet RxCUI 371716In current FDA listings -
Dose form (SCDF) Sublingual Tablet RxCUI 2048571In current FDA listingsClinical drug / strength (SCD) acetate 0.0277 MGRxCUI 2048716acetate 0.0553 MGRxCUI 2048720
Look up RxCUI 3251 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Desmopressin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Desmopressin belongs to the Vasopressin Analog class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 14 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Ferring Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.